245 related articles for article (PubMed ID: 10072560)
41. CD8+ cytolytic T lymphocytes become infected in vitro in the process of killing HIV-1-infected target cells.
De Maria A; Colombini S; Schnittman SM; Moretta L
Eur J Immunol; 1994 Mar; 24(3):531-6. PubMed ID: 7907291
[TBL] [Abstract][Full Text] [Related]
42. Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure.
Kent SJ; Greenberg PD; Hoffman MC; Akridge RE; McElrath MJ
J Immunol; 1997 Jan; 158(2):807-15. PubMed ID: 8992998
[TBL] [Abstract][Full Text] [Related]
43. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life.
Luzuriaga K; Holmes D; Hereema A; Wong J; Panicali DL; Sullivan JL
J Immunol; 1995 Jan; 154(1):433-43. PubMed ID: 7995957
[TBL] [Abstract][Full Text] [Related]
44. Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells.
Sistigu A; Bracci L; Valentini M; Proietti E; Bona R; Negri DR; Ciccaglione AR; Tritarelli E; Nisini R; Equestre M; Costantino A; Marcantonio C; Santini SM; Lapenta C; Donati S; Tataseo P; Miceli M; Cara A; Federico M
Vaccine; 2011 Apr; 29(18):3465-75. PubMed ID: 21382480
[TBL] [Abstract][Full Text] [Related]
45. Loss of T-cell cytotoxic responses in the course of HIV-1 infection.
Zerhouni B; Sanhadji K; Touraine JL
Thymus; 1997; 24(4):203-19. PubMed ID: 9493284
[TBL] [Abstract][Full Text] [Related]
46. HLA-binding regions of HIV-1 proteins. I. Detection of seven HLA binding regions in the HIV-1 Nef protein.
Choppin J; Martinon F; Connan F; Gomard E; Levy JP
J Immunol; 1991 Jul; 147(2):569-74. PubMed ID: 1712811
[TBL] [Abstract][Full Text] [Related]
47. Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin.
Delhem N; Hadida F; Gorochov G; Carpentier F; de Cavel JP; Andréani JF; Autran B; Cesbron JY
J Immunol; 1998 Aug; 161(4):2060-9. PubMed ID: 9712080
[TBL] [Abstract][Full Text] [Related]
48. Human immune response to HIV-1-Nef. I. CD45RO- T lymphocytes of non-infected donors contain cytotoxic T lymphocyte precursors at high frequency.
Lucchiari M; Niedermann G; Leipner C; Meyerhans A; Eichmann K; Maier B
Int Immunol; 1994 Nov; 6(11):1739-49. PubMed ID: 7865467
[TBL] [Abstract][Full Text] [Related]
49. Efficient antigen presentation to cytotoxic T lymphocytes by cells transduced with a retroviral vector expressing the HIV-1 Nef protein.
Robertson MN; Buseyne F; Schwartz O; Rivière Y
AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1217-23. PubMed ID: 7511396
[TBL] [Abstract][Full Text] [Related]
50. The generation of both T killer and Th cell clones specific for the tumor-associated antigen HER2 using retrovirally transduced dendritic cells.
zum Büschenfelde CM; Metzger J; Hermann C; Nicklisch N; Peschel C; Bernhard H
J Immunol; 2001 Aug; 167(3):1712-9. PubMed ID: 11466395
[TBL] [Abstract][Full Text] [Related]
51. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.
Pinto LA; Sullivan J; Berzofsky JA; Clerici M; Kessler HA; Landay AL; Shearer GM
J Clin Invest; 1995 Aug; 96(2):867-76. PubMed ID: 7635981
[TBL] [Abstract][Full Text] [Related]
52. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development.
Threlkeld SC; Wentworth PA; Kalams SA; Wilkes BM; Ruhl DJ; Keogh E; Sidney J; Southwood S; Walker BD; Sette A
J Immunol; 1997 Aug; 159(4):1648-57. PubMed ID: 9257824
[TBL] [Abstract][Full Text] [Related]
53. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes.
Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A
AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047
[TBL] [Abstract][Full Text] [Related]
54. Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes.
Bergmann CC; Yao Q; Ho CK; Buckwold SL
J Immunol; 1996 Oct; 157(8):3242-9. PubMed ID: 8871618
[TBL] [Abstract][Full Text] [Related]
55. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376
[TBL] [Abstract][Full Text] [Related]
56. Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine.
Cobb A; Roberts LK; Palucka AK; Mead H; Montes M; Ranganathan R; Burkeholder S; Finholt JP; Blankenship D; King B; Sloan L; Harrod AC; Lévy Y; Banchereau J
J Immunol Methods; 2011 Feb; 365(1-2):27-37. PubMed ID: 21093448
[TBL] [Abstract][Full Text] [Related]
57. Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.
Buseyne F; Chaix ML; Fleury B; Manigart O; Burgard M; Blanche S; Rouzioux C; Rivière Y
Virology; 1998 Oct; 250(2):316-24. PubMed ID: 9792842
[TBL] [Abstract][Full Text] [Related]
58. HIV-1 mRNA electroporation of PBMC: a simple and efficient method to monitor T-cell responses against autologous HIV-1 in HIV-1-infected patients.
Etschel JK; Hückelhoven AG; Hofmann C; Zitzelsberger K; Maurer K; Bergmann S; Mueller-Schmucker SM; Wittmann J; Spriewald BM; Dörrie J; Schaft N; Harrer T
J Immunol Methods; 2012 Jun; 380(1-2):40-55. PubMed ID: 22510580
[TBL] [Abstract][Full Text] [Related]
59. Human immune response to HIV-1 Nef. II. Induction of HIV-1/HIV-2 Nef cross-reactive cytotoxic T lymphocytes in peripheral blood lymphocytes of non-infected healthy individuals.
Lucchiari-Hartz M; Bauer M; Niedermann G; Maier B; Meyerhans A; Elchmann K
Int Immunol; 1996 Apr; 8(4):577-84. PubMed ID: 8671645
[TBL] [Abstract][Full Text] [Related]
60. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.
Tomiyama H; Akari H; Adachi A; Takiguchi M
J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
